Andrei Fodor

Andrei Fodor
申请预约
专科:
肿瘤科 放疗
职业:
肿瘤放射科医生
医疗机构:
放疗科 @ 圣拉斐尔科学研究医院
语言:
EN
IT
申请预约

个人简介

Andrei Fodor 博士是 IRCCS Ospedale San Raffaele 医院放疗科的放疗专家，由 Nadia Gisella Di Muzio 教授领导。

他于 1996 年毕业于罗马尼亚克卢日那波卡医药大学（University of Medicine and Pharmacy Cluj Napoca）内外科专业，并于 2001 年在该校专攻肿瘤放疗。之后，他于 2002 年在萨萨里大学获得内外科同等学位，并于 2006 年在米兰国立大学获得放射肿瘤学专业学位。

Fodor 医生采用先进的放射治疗技术（IGRT、IMRT）和立体定向放射治疗（使用伽玛刀和赛博刀）治疗病人。他跟踪治疗的患者包括：恶性胸膜间皮瘤、乳腺肿瘤、前列腺肿瘤、妇科肿瘤、中枢神经系统肿瘤。

他是欧洲放射治疗和肿瘤学会（ESTRO）、国际立体定向放射外科学会（ISRS）、意大利放射肿瘤协会（AIRO）以及意大利卵巢癌和妇科恶性肿瘤多中心试验（MITO）的成员。他还是《肿瘤学前沿》杂志的评论编辑。

他是米兰比可卡大学放射治疗专业学院的学术和手术导师。

他被授予国家科学资格，在竞争性科研部门 06/I1-诊断成像、放射治疗和神经放射学中担任大学二级教授（第 553/2021 号指令，由第 589/2021 号指令修正）。

他是许多出版物的作者和合著者，并积极参加该领域的国内和国际会议。

您需要预约吗？

联系我们，我们将为您妥善安排。
申请预约

出版物

最新出版物

Finding dose-volume constraints to reduce late rectal toxicity following tridimensional conformal radiotheraphy (3D-CRT) of prostate cancer
Radiother Oncol, 2003, Nov; 69 (2): 215-222. PMID: 1464396
Greco C, Mazzetta C, Catani F, Tossi G, Castiglioni S, Fodor A, Orecchia R.
Meta-analysis of Randomised Trials Comparing Gemcitabine- Based Doublets versus Gemcitabine Alone in Patients with Advanced and Metastatic Pancreatic Cancer
Drugs Aging, 2007, 24 (10): 865-879. DOI: 10.2165/00002512-200724100-00006
Banu E, Banu A, Fodor A, Landi B, Rougier Ph, Chatellier G, Andrieu JM, Oudard S, Pompidou G.
Dose escalation for prostate cancer using the three- dimensional conformal dynamic arc techinique: analysis of 542 consecutive patients
Int J Radiat Oncol Biol Phys, 2008, 71 (3): 784-794. doi: 10.1016/j.ijrobp.2007.10.041
Jereczek-Fossa BA, Vavassori A, Fodor C, Santoro L, Zerini D, Cattani F, Garibaldi C, Cambira R, Fodor A, Boboc GI, Vitolo V, Ivaldi GB, Mussi G, De Cobelli O, Orecchia R.
PET- Guided Dose Escalation Tomotherapy in Malignant Pleural Mesothelioma
Strahlenther Onkol 2011, 187 (11): 736-743. doi: 10.1007/s00066-011-2234-6
Fodor A, Fiorino C, Dell’Oca I, Broggi S, Pasetti M, Cattaneo GM, Gianolli L, Calandrino R, Di Muzio NG:
11C-Choline PET/CT as guide to radiation treatment planning of lymph-node relapses in prostate cancer patients
Eur J Nucl Med Mol Imaging 2014, 41(7): 1270-9. doi: 10.1007/s00259-014-2734-6
Picchio M, Berardi G, Fodor A, Busnardo E, Crivellaro C, Giovacchini G, Fiorino C, Kirienko M, Incerti E, Messa C, Gianolli L, Di Muzio N.
Higher-than-expected severe (Grade 3-4) late urinary toxicity after postprostatectomy hypofractionated radiotherapy: a single institution analysis of 1176 patients
Eur Urol 2014, 66(6):1024-30. doi: 10.1016/j.eururo.2014.06.012
Cozzarini C, Fiorino C, Deantoni C, Briganti A, Fodor A, La Macchia M, Noris Chiorda B, Rancoita PM, Suardi N, Zerbetto F, Calandrino R, Montorsi F, Di Muzio N.
Moderate hypofractionation with simultaneous integrated boost in prostate cancer: long-term results of a phase I-II study
Clin Oncol (R Coll Radiol) 2016, 28 (8): 490-500. doi: 10.1016/j.clon.2016.02.005
Di Muzio NG, Fodor A, Noris Chiorda B, Broggi S, Mangili P, Valdagni R, Dell’Oca I, Pasetti M, Deantoni CL, Chiara A, Berardi G, Briganti A, Calandrino R, Cozzarini C, Fiorino C.
Toxicity and efficacy of salvage 11C-Choline PET/CT- guided radiation therapy in patients with prostate cancer lymph nodal recurrence
BJU Int 2017, 119 (3): 406-413. 10.1111/bju.13510
Fodor A, Berardi G, Fiorino C, Picchio M, Busnardo E, Kirienko M, Incerti E, Dell’Oca I, Cozzarini C, Mangili P, Pasetti M, Calandrino R, Gianolli L, Di Muzio NG:
扩展阅读
Oligorecurrent prostate cancer limited to lymph nodes: getting our ducks in a row
World J Urol 2018;
Fodor A, Lancia A, Ceci F, Picchio M, Hoyer M, Jereczek-Fossa BA, Ost P, Castelucci P, Incerti E, Di Muzio N, Ingrosso G:
扩展阅读
A Multi-Institutional Analysis Comparing the Outcome and Toxicity of Stereotactic Body Radiotherapy and Elective Nodal Radiotherapy
Eur Urol 2019, doi: 10.1016/j.eururo.2019.07.009
De Bleser E, Jereczek-Fossa BA, Pasquier D, Zilli T, Van as N, Siva S, Fodor A, Dirix P, Gomez-Iturriaga A, Trippa F, Detti B, Ingrosso G, Triggiani L, Bruni A, Alongi F, Reynders D, De Meerleer G, Surgo A, Loukili K, Miralbell R, Silva P, Chander S, Di Muzio NG, Maranzano E, Francolini G, Lancia A, Tree A, Deantoni CL; Ponti E, Marvaso G, Goetghebeur E, Ost P. Metastasis-directed Therapy in Treating Nodal Oligorecurrent Prostate Cancer:
A large, multicenter, retrospective study on efficacy and safety of stereotactic body radiotherapy (SBRT) in oligometastatic ovarian cancer (MITO RT1 Study)
A collaboration of MITO, AIRO GYN, and MaNGO Groups. The Oncologist 2019,
Macchia G, Lazzari R, Colombo N, Laliscia C, Capelli G, D’Agostino GR, Deodato F, Maranzano E, Ippolito E, Ronchi S, Paiar F, Scorsetti M; Cilla S, Ingargiola R, Huscher A, Cerrotta AM, Fodor A, Vicenzi L, Russo D, Borghesi S, Perrucci E, Pignata S, Aristei C, Morganti AG, Scambia G, Valentini V, Jereczek-Fossa BA, Ferrandina G.
扩展阅读
Impact of molecular subtype on 1325 early-stage breast cancer patients homogeneously treated with hypofractionated radiotherapy without boost: Should the indications for radiotherapy be more personalized?
Breast, 2021 Feb;55:45-54. doi: 10.1016/j.breast.2020.12.004.
A Fodor, C Brombin, P Mangili, F Borroni, M Pasetti, R Tummineri, F Zerbetto, B Longobardi, L Perna, I Dell'Oca, CL Deantoni, AM Deli, A Chiara, S Broggi, R Castriconi, P Esposito, N Slim, P Passoni, S Baroni, SL Villa, PMV Rancoita, C Fiorino, A Del Vecchio, G Bianchini, OD Gentilini, MS Di Serio, NG Di Muzio.
Ten Year Results of Extensive Nodal Radiotherapy and Moderately Hypofractionated Simultaneous Integrated Boost in Unfavorable Intermediate-, High-, and Very High-Risk Prostate Cancer
Cancers (Basel). 2021 Oct 3;13(19):4970. doi: 10.3390/cancers13194970
Di Muzio NG, Deantoni CL, Brombin C, Fiorino C, Cozzarini C, Zerbetto F, Mangili P, Tummineri R, Dell'Oca I, Broggi S, Pasetti M, Chiara A, Rancoita PMV, Del Vecchio A, Di Serio MS, Fodor A.
A multicenter LArge retrospectIve daTabase on the personalization of stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer
The LaIT-SABR study. Radiother Oncol. 2022 Jan;166:92-99. doi: 10.1016/j.radonc.2021.10.023
L Nicosia, D Franceschini, F Perrone-Congedi, F Casamassima, MA Gerardi, M Rigo, R Mazzola, M Perna, V Scotti, A Fodor, A Iurato, F Pasqualetti, G Gadducci, S Chiesa, RM Niespolo, A Bruni, G Alicino, L Frassinelli, P Borghetti, A Di Marzo, A Ravasio, B De Bari, M Sepulcri, D Aiello, G Mortellaro, C Sangalli, M Franceschini, G Montesi, FM Aquilanti, G Lunardi, R Valdagni, I Fazio, G Scarzello, L Corti, V Vavassori, E Maranzano, SM Magrini, S Arcangeli, MA Gambacorta, V Valentini, F Paiar, S Ramella, NG Di Muzio, L Livi, BA Jereczek-Fossa, MF Osti, M Scorsetti, F Alongi.
Toxicity of Hypofractionated Whole Breast Radiotherapy Without Boost and Timescale of Late Skin Responses in a Large Cohort of Early-Stage Breast Cancer Patients
Clin Breast Cancer. 2022 Jun;22(4):e480-e487. doi: 10.1016/j.clbc.2021.11.008
Fodor A, Brombin C, Mangili P, Tummineri R, Pasetti M, Zerbetto F, Longobardi B, Galvan AS, Deantoni CL, Dell'Oca I, Castriconi R, Esposito PG, Deli AM, Rancoita PMV, Fiorino C, Vecchio AD, Di Serio MS, Di Muzio NG.

您需要预约吗？

联系我们，我们将为您妥善安排。
申请预约